Clinical utility of breast magnetic resonance imaging in patients presenting with primary breast cancer.(Clinical report)

From: Baylor University Medical Center Proceedings | Date: July 1, 2007| Author: Dao, Tuoc N.; Lamont, Jeffrey P.; Knox, Sally M. | Copyright information

Since magnetic resonance imaging (MRI) of the breast has been shown to be sensitive in identifying the extent of the primary tumor and other foci of cancer, we examined its clinical utility in the surgical management of breast cancer patients. From January 2004 to April 2007, 117 patients with newly diagnosed breast cancer underwent bilateral MRI prior to definitive surgical management. Additional lesions were found in 27 patients (23.1%) in the ipsilateral breast and 19 patients (1...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Management of patients with breast cancer. (Continuing professional development: oncology).
Nursing Standard ; NS197 McCready T (2003) Management of patients with breast cancer. Nursing Standard. 17, 41, 45-53. Date of acceptance: May 19 2003. Summary Breast cancer is the most common cancer in the UK, with over 39,500 women diagnosed every year (Cancer Research UK 2003). The author examines the biological,
Breast cancer drug approved for Scots 1-in-5 patients to benefit in GBP2 Herceptin move
Evening Times ; ... to see the roll-out of this drug over the coming months without having to find funding from other frontline provision." Health Minister Andy Kerr said: "It's good news for patients and I expect NHS boards to move swiftly to implement this advice."
'Give breast cancer drugs on NHS to all patients'
Evening Standard - London ; ... Nottingham City Hospital, said women with advanced breast cancer had very different treatment requirements. "It is extremely good news that women now will have access to a range of effective treatment options, so that the most appropriate therapy can be tailored ...
High Preoperative CA 15-3 Concentrations Predict Adverse Outcome in Node-Negative and Node-Positive Breast Cancer: Study of 600 Patients with Histologically Confirmed Breast Cancer
Clinical Chemistry ; Background: CA 15-3 is the most widely used serum marker in breast cancer. Currently, its main uses are in the surveillance of patients with diagnosed disease and monitoring the treatment of patients with advanced disease. Methods: Preoperative CA 15-3 concentrations were measured prospectively in
Breast cancer research shifts to targeting of drugs to patients
Drug Topics ; Researchers at the Department of Defense's annual Era of Hope Breast Cancer Research Program meeting in Orlando, Fla., shared new techniques to target the right patients to receive cancer drugs, as well as preliminary research on the development of more effective medicines. Some of the DOD's $150